It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Prurigo Nodularis Treatment Study

Clinical Trial Title: 
A study to assess the safety and efficacy of nemolizumab (CD14152) in subjects with prurigo nodularis.
Clinical Trial Protocol ID: 
17032004
Clinical Trial Investigator Name: 
James O. Ertle, MD
Clinical Trial Protocol Description: 

Rush Dermatology seeks volunteers with a diagnosis of prurigo nodularis for a clinical trial testing an injectable medication. All office visits and treatments are provided free of charge. Anticipated results are a possible new treatment option for the itch associated with prurigo nodularis. The study will last about 6 months.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Have a diagnosis of prurigo nodularis for at least 6 months.
  • Are at least 18 years of age or older.
  • Have at least 20 nodules on the entire body.
  • Have severe itching.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Dermatology
Contact Email: 
Contact Phone: 
(312) 563-4001
Contact Name: 
Carmen Petrizzo or Danica Uzelac